Letters to the Editor

Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK’s Haematological Malignancy Research Network

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD
Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD
Queen’s Centre for Oncology and Haematology, Castle Hill Hospital, Cottingham, HU16 5JQ
Haematological Malignancy Diagnostic Service, St. James’s Institute of Oncology, Leeds, LS9 7LP
Haematological Malignancy Diagnostic Service, St. James’s Institute of Oncology, Leeds, LS9 7LP
Department of Haematology, Leeds Cancer Centre, St James’s University Hospital, LS9 7LP
Department of Haematology, Leeds Cancer Centre, St James’s University Hospital, LS9 7LP
Department of Haematology, Leeds Cancer Centre, St James’s University Hospital, LS9 7LP
Haematologica Early view Mar 20, 2025 https://doi.org/10.3324/haematol.2024.287095